{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:34Z","timestamp":1791225994333,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2968,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.virol.2005.04.004","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T16:43:56Z","timestamp":1115397836000},"page":"149-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"title":["Universal influenza A vaccine: Optimization of M2-based constructs"],"prefix":"10.1016","volume":"337","author":[{"given":"Marina","family":"De Filette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Min Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Birkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tonkyro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Fiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.04.004_bib1","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.virol.2005.04.004_bib2","unstructured":"Anonymous, 2003. WHO-CSR, Update 94, July 3 (http:\/\/www.who.int\/csr\/don\/2003_07_03)."},{"key":"10.1016\/j.virol.2005.04.004_bib3","unstructured":"Anonymous, 2004. WHO-CSR, Update Dec. 30 (http:\/\/www.who.int\/csr\/don\/2004_12_30\/en\/)."},{"key":"10.1016\/j.virol.2005.04.004_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines","volume":"1","author":"Aucouturier","year":"2002","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2005.04.004_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/0022-1317-74-1-143","article-title":"Antibody response to the M2 protein of influenza A virus expressed in insect cells","volume":"74","author":"Black","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.04.004_bib6","series-title":"PCT Applications WO 99\/40934 and WO 02\/14478","author":"Birkett","year":"1999"},{"key":"10.1016\/j.virol.2005.04.004_bib7","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1128\/IAI.70.12.6860-6870.2002","article-title":"A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts","volume":"70","author":"Birkett","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2005.04.004_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.284.13.1655","article-title":"Effectiveness and cost\u2013benefit of influenza vaccination of healthy working adults: a randomized controlled trial","volume":"284","author":"Bridges","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2005.04.004_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(97)11212-0","article-title":"Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus","volume":"351","author":"Claas","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.04.004_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza","volume":"354","author":"Cox","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.04.004_bib11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/iai.63.5.1617-1623.1995","article-title":"Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity","volume":"63","author":"Dickinson","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2005.04.004_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/14760584.2.2.219","article-title":"Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529","volume":"2","author":"Evans","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2005.04.004_bib13","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1098\/rstb.2001.0980","article-title":"Soluble recombinant influenza vaccines","volume":"356","author":"Fiers","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond., B Biol. Sci."},{"key":"10.1016\/j.virol.2005.04.004_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u201cuniversal\u201d human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2005.04.004_bib16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0264-410X(99)00005-5","article-title":"Modified M2 proteins produce heterotypic immunity against influenza A virus","volume":"17","author":"Frace","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib17","first-page":"215","article-title":"Bacterial toxins as mucosal adjuvants","volume":"236","author":"Freytag","year":"1999","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2005.04.004_bib18","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds","volume":"183","author":"Holsinger","year":"1991","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virol.2005.04.004_bib20","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.04.004_bib21","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib22","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.04.004_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918\u20131920 \u201cSpanish\u201d influenza pandemic","volume":"6","author":"Johnson","year":"2002","journal-title":"Bull Hist Med."},{"key":"10.1016\/j.virol.2005.04.004_bib24","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect Immun."},{"key":"10.1016\/j.virol.2005.04.004_bib25","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.96.5.1915","article-title":"Native display of complete foreign protein domains on the surface of hepatitis B virus capsids","volume":"96","author":"Kratz","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.04.004_bib26","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1073\/pnas.78.7.4170","article-title":"Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins","volume":"78","author":"Lamb","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.04.004_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.virol.2005.04.004_bib28","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1128\/JVI.75.11.5416-5420.2001","article-title":"Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice","volume":"75","author":"Liang","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.004_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-8244(03)00009-9","article-title":"N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication","volume":"35","author":"Liu","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.virol.2005.04.004_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0264-410X(02)00259-1","article-title":"B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H. pylori seronegative individuals","volume":"21","author":"Losonsky","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0264-410X(01)00452-2","article-title":"Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine","volume":"20","author":"Lu","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib33","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.04.004_bib55","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1515\/BC.1999.038","article-title":"The core antigen of hepatitis B virus as a carrier for immunogenic peptides","volume":"380","author":"Murray","year":"1999","journal-title":"Biol. Chem."},{"key":"10.1016\/j.virol.2005.04.004_bib35","unstructured":"Neirynck, S., Min Jou, W., Fiers, W., 1997. New immunoprotective influenza antigen and its use in vaccination. Patent application WO99\/07839 (18.02.1999); Priority date 1997.08.05."},{"key":"10.1016\/j.virol.2005.04.004_bib36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2005.04.004_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.303.5658.609","article-title":"WHO ramps up bird flu vaccine efforts","volume":"303","author":"Normile","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.04.004_bib38","first-page":"117","article-title":"Influenza subunit vaccine\u2014Ten years experience","volume":"3","author":"Palache","year":"1992","journal-title":"Eur. J. Clin. Res."},{"key":"10.1016\/j.virol.2005.04.004_bib39","series-title":"Survival Analysis: a Practical Approach","author":"Palmar","year":"1995"},{"key":"10.1016\/j.virol.2005.04.004_bib40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.1985.03350320060017","article-title":"Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic","volume":"53","author":"Patriarca","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2005.04.004_bib41","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0140-6736(99)03311-5","article-title":"Human infection with influenza H9N2","volume":"354","author":"Peiris","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.04.004_bib42","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0966-842X(02)02426-5","article-title":"Taking toll: lipid A mimetics as adjuvants and immunomodulators","volume":"10","author":"Persing","year":"2002","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virol.2005.04.004_bib43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.virol.2005.04.004_bib44","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0264-410X(00)00448-5","article-title":"Influenza vaccines: a review and rationale for use in developed and underdeveloped countries","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.04.004_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Pumpens","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.virol.2005.04.004_bib46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/jvi.63.2.798-808.1989","article-title":"Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus","volume":"63","author":"Salfeld","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.004_bib47","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1128\/JVI.72.8.6678-6688.1998","article-title":"Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong","volume":"72","author":"Suarez","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.004_bib48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-79-2-291","article-title":"Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection","volume":"79","author":"Tamura","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.04.004_bib49","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.004_bib50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(08)60808-8","article-title":"Core particles of hepatitis B virus as carrier for foreign epitopes","volume":"50","author":"Ulrich","year":"1998","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2005.04.004_bib51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(04)15892-3","article-title":"Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines","volume":"363","author":"Webby","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2005.04.004_bib52","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1021\/bi00015a003","article-title":"Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly","volume":"34","author":"Wingfield","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2005.04.004_bib53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"Wynne","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.virol.2005.04.004_bib54","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1016\/S0021-9258(19)50440-9","article-title":"The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern","volume":"267","author":"Zheng","year":"1992","journal-title":"J. Biol. Chem."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:35:53Z","timestamp":1758584153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0042682205002114"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.04.004","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Universal influenza A vaccine: Optimization of M2-based constructs","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}